| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
3 companies
Thilo Schroeder last filed a Form 4 in December 2024, as Director at SPRY. The filings on record cover 3 companies. Thilo Schroeder's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Thilo Schroeder a strong insider score of 80/100, based on 82 past trades. Over a 12-month horizon, 93.9% of those trades were profitable, with an average 12-month return of +43.0%.
At the last filing, the largest reported position was 760,869 shares of RVMD. Net of sales, the RVMD filings show accumulation of 4,025,662 shares.
Thilo Schroeder has 39 Form 4 filings on record from February 2020 to December 2024, across 3 companies: Director at Revolution Medicines (RVMD), 2020–2024; Director at PMV Pharmaceuticals (PMVP), 2020–2021; Director at ARS Pharmaceuticals (SPRY), 2020.
The 144 reported transactions were 97 open-market sales, 38 open-market purchases, 5 conversions and 2 stock awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 10 purchases worth about $128.3M and 27 sales worth about $38.3M.
The largest open-market purchase was 1,304,347 shares of RVMD at an average $46.00 on December 5, 2024, about $60.0M. Twelve months later RVMD was up 68%.
The largest open-market sale was 136,436 shares of PMVP at an average $34.31 on April 8, 2021, about $4.7M. Twelve months later PMVP was down 38%.
Shares as reported in the last Form 4 for each company; the most recent is from December 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2024 | RVMD Revolution Medicines, Inc. | Director | Buy | 1,304,347 | $46.00 | $59,999,962.00 | -240.0% | -16.2% | +68.4% | |
| Mar 10, 2023 | RVMD Revolution Medicines, Inc. | Director | Buy | 650,000 | $21.76 | $14,145,604.00 | +72.0% | +19.7% | +55.3% | |
| Jul 22, 2022 | RVMD Revolution Medicines, Inc. | Director | Buy | 250,000 | $20.00 | $5,000,000.00 | +25.7% | -20.9% | +19.8% | |
| Mar 28, 2022 | RVMD Revolution Medicines, Inc. | Director | Buy | 42,725 | $24.79 | $1,059,247.30 | +4.6% | -25.0% | -15.8% | |
| Mar 24, 2022 | RVMD Revolution Medicines, Inc. | Director | Buy | 232,364 | $23.63 | $5,489,624.89 | +33.4% | -26.5% | -15.3% | |
| Mar 21, 2022 | RVMD Revolution Medicines, Inc. | Director | Buy | 168,051 | $20.40 | $3,429,032.74 | +31.8% | -12.4% | +2.9% | |
| Mar 11, 2022 | RVMD Revolution Medicines, Inc. | Director | Buy | 43,510 | $20.63 | $897,763.04 | +9.0% | -6.2% | +3.0% | |
| Mar 9, 2022 | RVMD Revolution Medicines, Inc. | Director | Buy | 246,438 | $18.91 | $4,660,855.81 | +103.4% | -3.7% | +6.0% | |
| Mar 4, 2022 | RVMD Revolution Medicines, Inc. | Director | Buy | 238,227 | $18.53 | $4,415,232.97 | New | -0.1% | +47.0% | |
| Oct 6, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Director | Sell | 800 | $30.15 | $24,120.00 | - | -19.1% | -56.7% |